Home › Marginaalzone-lymfoom › New York › New York City
Marginaalzone-lymfoom klinische studies in New York City, NY
11 studies voor Marginaalzone-lymfoom zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruterenFase 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
Epco, Zanu, Ritux for R/R FL or MZL
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruterenFase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of ARC-02 in B-cell NHL
RekruterenFase 1
- NYU Langone, New York
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center - Bergen, New York
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
RekruterenObservatieonderzoek
- Weill Cornell Medical, New York
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
RekruterenFase 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruterenFase 1
- Weill Cornell, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, New York
Marginaalzone-lymfoom studies in andere steden
- Durham, NC12 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Houston, TX8 studies
- Columbus, OH8 studies
- Edison, NJ8 studies
- Nashville, TN7 studies
- Miami, FL7 studies
- Denver, CO7 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.